Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.

نویسندگان

  • Christopher A Haiman
  • Laure Dossus
  • V Wendy Setiawan
  • Daniel O Stram
  • Alison M Dunning
  • Gilles Thomas
  • Michael J Thun
  • Demetrius Albanes
  • David Altshuler
  • Eva Ardanaz
  • Heiner Boeing
  • Julie Buring
  • Noël Burtt
  • Eugenia E Calle
  • Stephen Chanock
  • Françoise Clavel-Chapelon
  • Graham A Colditz
  • David G Cox
  • Heather Spencer Feigelson
  • Susan E Hankinson
  • Richard B Hayes
  • Brian E Henderson
  • Joel N Hirschhorn
  • Robert Hoover
  • David J Hunter
  • Rudolf Kaaks
  • Laurence N Kolonel
  • Loïc Le Marchand
  • Per Lenner
  • Eiliv Lund
  • Salvatore Panico
  • Petra H Peeters
  • Malcolm C Pike
  • Elio Riboli
  • Anne Tjonneland
  • Ruth Travis
  • Dimitrios Trichopoulos
  • Sholom Wacholder
  • Regina G Ziegler
چکیده

The CYP19A1 gene encodes the enzyme aromatase, which is responsible for the final step in the biosynthesis of estrogens. In this study, we used a systematic two-step approach that included gene resequencing and a haplotype-based analysis to comprehensively survey common genetic variation across the CYP19A1 locus in relation to circulating postmenopausal steroid hormone levels and breast cancer risk. This study was conducted among 5,356 invasive breast cancer cases and 7,129 controls comprised primarily of White women of European descent drawn from five large prospective cohorts within the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. A high-density single-nucleotide polymorphism (SNP) map of 103 common SNPs (> or =5% frequency) was used to identify the linkage disequilibrium and haplotype patterns across the CYP19A1 locus, and 19 haplotype-tagging SNPs were selected to provide high predictability of the common haplotype patterns. We found haplotype-tagging SNPs and common haplotypes spanning the coding and proximal 5' region of CYP19A1 to be significantly associated with a 10% to 20% increase in endogenous estrogen levels in postmenopausal women [effect per copy of the two-SNP haplotype rs749292-rs727479 (A-A) versus noncarriers; P = 4.4 x 10(-15)]. No significant associations were observed, however, with these SNPs or common haplotypes and breast cancer risk. Thus, although genetic variation in CYP19A1 produces measurable differences in estrogen levels among postmenopausal women, the magnitude of the change was insufficient to contribute detectably to breast cancer.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

اثرات استروژن درمانی در زنان یائسه و ارتباط آن با سرطان پستان

Low levels of endogenous estrogens in postmenopausal women lead to several clinical problems. Some of these problems can be resolved by estrogen replacement therapy. The role of estrogen therapy in increasing the risk of breast cancer has not been well known yet. So, it was decided to study this controversial issue. In this study, 122 postmenopausal women, ranging in age from 46 to 61 years, we...

متن کامل

Serum Liver proteins and 17β-estradiol in Postmenopausal Women with Breast Cancer

Background: Breast cancer is a hormone-dependent malignancy that is associated with estrogen and progesterone interactions. The liver is the most important organ to be affected by the metastasis of breast cancer, which causes functional impairment. We compared levels of obesity, 17β-estradiol, and secreted proteins in postmenopausal women with breast cancer but without hepatic symptoms to those...

متن کامل

Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer

Genetic variants in CYP19A1, the gene encoding aromatase, have been reported to be associated with circulating estrogen concentrations, a key risk factor for breast cancer. The mechanism underlying this association is still unclear; it has been suggested that some of these variants may alter the expression and/or activity of aromatase. Here we analyzed the expression of intra-tumoral CYP19A1 me...

متن کامل

Relationships between Body Mass Index, Serum Leptin Levels, and 17β-Estradiol in Postmenopausal Women with Breast Cancer: A Case-Control Study

Introduction: There is a close relationship between the incidence of breast cancer and fat intake in different populations. Overweight and obesity during menopause can increase the risk of breast cancer in women. Hormones like estrogen and leptin are factors that affect the growth and proliferation of breast cells. The main purpose of this study was to evaluate the relationships between body ma...

متن کامل

Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.

Although the role of estrogen in the etiology of ovarian cancer is uncertain, there is increasing evidence that hormone replacement therapy is a risk factor for ovarian malignancy. The production of estrogen involves the conversion of androgens via P450 aromatase, encoded by the CYP19A1 gene. Genetic variation in two CYP19A1 single-nucleotide polymorphisms (SNPs), rs749292 and rs727479, has bee...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer research

دوره 67 5  شماره 

صفحات  -

تاریخ انتشار 2007